Overview of Smart Cancer Nanomedicine MarketThe Global Smart Cancer Nanomedicine Market is emerging as a revolutionary force ...

Chart review has mostly been a manual process, has been prone to error, and is an area where extracting actionable insights ...

New findings may help patients with low to moderate risk of tumor lysis syndrome while reducing the burden for hematologists.

ImmunityBio, Inc.'s advances with Anktiva & rBCG show promise amid financial hurdles. Click here to find out why IBRX stock ...

Like Tom, I have experienced some “waves of grief.” ...

They offered oncofertility and fibroids treatment ... cancer patients and career-driven individuals given the advancements in reproductive health technology. “Fertility preservation is the ...

You’re in a comedy club, and the guy onstage has gone quiet. He looks down at his feet, fidgets with the microphone, smiles a ...

If your tumor is benign, it won’t require treatment, but if it is malignant ... However, the following chart summarizes a few things you can watch for to see whether it’s more likely to ...

Actively-treated patients treated for four weeks were able to read 13.5 more letters on an eye chart ... prostate cancer who have suspected metastasis and are candidates for initial definitive therapy ...

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

President Donald Trump has announced plans for sweeping tariffs. He said Wednesday, “Our country has been looted, pillaged, ...

VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, ...